Nuclear Radiology: Page 40

ESR, IAEA partner to advance imaging

By AuntMinnieEurope.com staff writers

The European Society of Radiology (ESR) and International Atomic Energy Agency (IAEA) are collaborating to promote the education and use of diagnostic imaging in Europe.

February 28, 2017

PET/CT well-suited to follow up organ transplants

By Wayne Forrest

With high sensitivity and negative predictive value, FDG-PET/CT is very accurate in diagnosing suspected malignancies or infection in patients after a solid-organ transplant, according to a study in the March issue of the European Journal of Nuclear Medicine and Molecular Imaging

February 16, 2017

EANM looks to create guide to common terms

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine (EANM) has created a guide that defines and standardizes the meaning of terms that clinicians use in their respective daily practices.

February 14, 2017

Radiopharmaceuticals market slated for strong growth

By AuntMinnieEurope.com staff writers

The global radiopharmaceuticals market generated 4.5 billion euros in revenues in 2016 and is expected to increase at a 5.9% compound annual growth rate (CAGR) to reach a value of 8 billion euros by 2026, according to a new report by market research firm Future Market Insights.

February 14, 2017

New PET tracer advances prostate cancer detection

By AuntMinnieEurope.com staff writers

Researchers have developed a new PET radiotracer designed to detect both early and advanced prostate cancer and help direct treatment, according to a study in the February issue of the Journal of Nuclear Medicine.

February 7, 2017

IBA Molecular finalizes purchase of Mallinckrodt unit

By AuntMinnieEurope.com staff writers

Radiopharmacy vendor IBA Molecular has successfully completed its acquisition of Mallinckrodt's nuclear imaging business.

January 29, 2017

PET/CT remains best option for head, neck cancer

By Wayne Forrest

While PET/MRI shows great promise in a multitude of clinical applications, German researchers have found that the hybrid modality's performance in evaluating head and neck cancer appears no better than that of tried-and-true PET/CT.

January 11, 2017

Brain tumor diagnosis, therapeutics set for growth

By AuntMinnieEurope.com staff writers

A higher incidence of various brain cancers and a growing geriatric population will propel the global market for brain tumor diagnosis and therapeutics products to reach $773.1 million in revenues by 2025, according to a new report by market research firm Grand View Research.

January 9, 2017

New therapeutic agent could treat prostate cancer

By AuntMinnieEurope.com staff writers

German researchers are highlighting the potential of a new therapeutic agent for radioligand therapy of patients with metastatic castration-resistant prostate cancer in a study published in the January issue of the Journal of Nuclear Medicine.

January 5, 2017

PET/MRI head scans reveal important incidental findings

By Wayne Forrest

Adding a scan of the entire head to a routine whole-body PET/MRI protocol reveals a significant number of incidental findings in the brain in asymptomatic cancer patients, found a study presented at RSNA 2016.

January 4, 2017

GE purchases expanded rights to Rapiscan stress agent

By AuntMinnieEurope.com staff writers

GE Healthcare's Life Sciences unit has purchased exclusive rights to produce and sell the Rapiscan pharmacological stress agent in territories outside of the U.S., Canada, and Mexico.

January 2, 2017

3D-printed kidney phantom advances SPECT/CT calibration

By Wayne Forrest

German researchers have developed a low-cost 3D printing technology that can be used to create patient-specific organ models of varying sizes and shapes, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 14, 2016

Previous Page

Page 40 of 90

Next Page